Baseline laboratory parameters for preliminary diagnosis of COVID-19 among children
a cross-sectional study
Palavras-chave:
COVID-19, SARS-CoV-2, Child, BiomarkersResumo
BACKGROUND: Clinical judgment of initial baseline laboratory tests plays an important role in triage and preliminary diagnosis among coronavirus disease 2019 (COVID-19) patients. OBJECTIVES: To determine the differences in laboratory parameters between COVID-19 and COVID-like patients, and between COVID-19 and healthy children. Additionally, to ascertain whether healthy children or patients with COVID-like symptoms would form a better control group.DESIGN AND SETTING: Cross-sectional study at the Institute for Child and Youth Health Care of Vojvodina, Novi Sad, Serbia. METHODS: A retrospective study was conducted on 42 pediatric patients of both sexes with COVID-19. Hematological parameters (white blood cell count, absolute lymphocyte count and platelet count) and biochemical parameters (natremia, kalemia, chloremia, aspartate aminotransferase [AST], alanine amino-transferase [ALT], lactate dehydrogenase [LDH] and C-reactive protein [CRP]) were collected. The first control group was formed by 80 healthy children and the second control group was formed by 55 pediatric patients with COVID-like symptoms. RESULTS: Leukocytosis, lymphopenia, thrombocytosis, elevated systemic inflammatory index and neutro-phillymphocyte ratio, hyponatremia, hypochloremia and elevated levels of AST, ALT, LDH and CRP were present in COVID patients, in comparison with healthy controls, while in comparison with COVID-like controls only lymphopenia was determined. CONCLUSIONS: The presence of leukocytosis, lymphopenia, thrombocytosis, elevated systemic inflammatory index and neutrophil-lymphocyte ratio, hyponatremia, hypochloremia and elevated levels of AST, ALT, LDH and CRP may help healthcare providers in early identification of COVID-19 patients. Healthy controls were superior to COVID-like controls since they provided better insight into the laboratory characteristics of children with novel betacoronavirus (SARS-CoV-2) infection.
Downloads
Referências
Li Q, Guan X, Wu P, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020;382(13):1199-207. PMID: 31995857; https://doi.org/10.1056/NEJMoa2001316.
Worldometers. COVID-19 coronavirus pandemic. Available from: https://www.worldometers.info/coronavirus/ Accessed in 2022 (Jun 27).
Institute for Public Health Reports - Coronavirus COVID-19. Available from: https://covid19.rs/eng-instituteforpublichealth-updates/ Accessed in 2022 (Jun 27).
Dhama K, Khan S, Tiwari R, et al. Coronavirus Disease 2019-COVID 19. Clin Microbiol Rev. 2020;33(4):e00028-20. PMID: 32580969; https://doi.org/10.1128/CMR.00028-20.
Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020; 368:m606:1-7. PMID: 32075786; https://doi.org/10.1136/bmj.m606.
Henry BM, Lippi G, Plebani M. Laboratory abnormalities in children with novel coronavirus disease 2019. Clin Chem Lab Med. 2020;58(7):1135-8. PMID: 32172227; https://doi.org/10.1515/cclm-2020-0272.
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. PMID: 31986264; https://doi.org/10.1016/S0140-6736(20)30183-5.
Tiwari DN, Nath DD, Madan DJ, et al. Novel Insights into the Hematological Parameter Abnormalities in Pediatric COVID-19 Cases: Observation from A Preliminary Study of 11 Pediatric COVID-19 Cases in A Tertiary Care Center of North India. Saudi J Pathol Microbiol. 2020;5:276-84. https://doi.org/10.36348/sjpm.2020.v05i05.010.
De Carvalho H, Richard MC, Chouihed T, et al. Electrolyte imbalance in COVID-19 patients admitted to the Emergency Department: a case-control study. Intern Emerg Med. 2021;23:1-6. PMID: 33484453; https://doi.org/10.1007/s11739-021-02632-z.
Moon AM, Barritt AS. Elevated Liver Enzymes in Patients with COVID-19: Look, but Not Too Hard. Dig Dis Sci. 2021;66(6):1767-9. PMID: 32875529; https://doi.org/10.1007/s10620-020-06585-9.
Henry BM, Aggarwal G, Wong J, et al. Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis. Am J Emerg Med. 2020;38(9):1722-6. PMID: 32738466; https://doi.org/10.1016/j.ajem.2020.05.073.
Mardani R, Vasmehjani AA, Zali F, et al. Laboratory Parameters in Detection of COVID-19 Patients with Positive RT-PCR; a Diagnostic Accuracy Study. Arch Acad Emerg Med. 2020;8(1):4-8. PMID: 32259132.
Ali N. Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19. J Med Virol. 2020:92:2409-11. PMID: 32516845; https://doi.org/10.1002/jmv.26097.
Ma H, Hu J, Tian J, et al. A single-center, retrospective study of COVID-19 features in children: a descriptive investigation. BMC Med. 2020;18(1):123. PMID: 32370747; https://doi.org/10.1186/s12916-020-01596-9.
Soraya GV, Ulhaq ZS. Crucial laboratory parameters in COVID-19 diagnosis and prognosis: An updated meta-analysis. Med Clin Barc. 2020;155(4):143-51. PMID: 32864456; https://doi.org/10.1016/j.medcle.2020.05.004.
Garciá-Tardón N, Abbes AP, Gerrits A, Slingerland RJ, Den Besten G. Laboratory parameters as predictors of mortality in COVID-19 patients on hospital admission. J Lab Med. 2020;44(6):357-9. https://doi.org/10.1515/labmed-2020-0087.
Lippi G, Plebani M. The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks. Clin Chem Lab Med. 2020;58(7):1063-9. PMID: 32191623; https://doi.org/10.1515/cclm-2020-0240.
Jiehao C, Jin X, Daojiong L, et al. A case series of children with 2019 novel coronavirus infection: Clinical and epidemiological features. Clin Infect Dis. 2020;71(6):1547-51. PMID: 32112072; https://doi.org/10.1093/cid/ciaa198.
Wang D, Ju XL, Xie F, et al. Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China. Chinese J Pediatr. 2020;58(4):269-74. PMID: 32118389; https://doi.org/10.3760/cma.j.cn112140-20200225-00138.
Jung RG, Di Santo P, Clifford C, et al. Methodological quality of COVID-19 clinical research. Nat Commun. 2021;12(1):1-10. PMID: 33574258; https://doi.org/10.1038/s41467-021-21220-5.
Yusuf E, Maiwald M. COVID-19, equipoise and observational studies: a reminder of forgotten issues. Infection. 2021;49(2):371-3. PMID: 32588335; https://doi.org/10.1007/s15010-020-01466-9.
Dettori JR, Norvell DC, Chapman JR. Grab Control! Choosing the Right Comparison Group in an Observational Study. Glob Spine J. 2019;9(4):456-8. https://doi.org/10.1177/2192568219847206.
Goudouris ES. Laboratory diagnosis of COVID-19. J Pediatr (Rio J). 2021;97(1):7-12. PMID: 32882235; https://doi.org/10.1016/j.jped.2020.08.001.
Fathi N, Rezaei N. Lymphopenia in COVID-19: Therapeutic opportunities. Cell Biol Int. 2020;44(9):1792-7. PMID: 32458561; https://doi.org/10.1002/cbin.11403.
Zheng SY, Xiao QY, Xie XH, et al. Association between secondary thrombocytosis and viral respiratory tract infections in children. Sci Rep. 2016;6:22964. PMID: 26965460; https://doi.org/10.1038/srep22964.
Usul E, San I, Bekgöz B, Sahin A. Role of hematological parameters in COVID-19 patients in the emergency room. Biomark Med. 2020;14(13):1207-15. PMID: 32692248; https://doi.org/10.2217/bmm-2020-0317.
Wang L. C-reactive protein levels in the early stage of COVID-19. Médecine Mal Infect. 2020;50(4):332-4. PMID: 32243911; https://doi.org/10.1016/j.medmal.2020.03.007.
Downloads
Publicado
Como Citar
Edição
Seção
Licença

Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.